Neuronetics, Inc. SEC filings STIM

Neuronetics, Inc. has 719 filings in SEC EDGAR's recent list, going back to Apr 15, 2003. Its latest annual report, Form 10-K, was filed on Mar 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Neuronetics, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Aug 11, 2026 —
S-3 Shelf registration Mar 17, 2026 —
424B5 Prospectus supplement Aug 6, 2025 —
S-3 Shelf registration Jul 3, 2025 —
424B5 Prospectus supplement Feb 10, 2025 —
424B5 Prospectus supplement Feb 6, 2025 —
S-8 Employee stock plan registration Feb 4, 2025 —
S-3/A Filing Nov 9, 2022 —
S-3 Shelf registration Aug 5, 2022 —
S-8 Employee stock plan registration Aug 5, 2022 —
424B5 Prospectus supplement Feb 1, 2021 —
424B5 Prospectus supplement Jan 28, 2021 —
S-8 Employee stock plan registration Jan 19, 2021 —
S-3 Shelf registration Aug 6, 2019 —
S-8 Employee stock plan registration Jul 26, 2018 —
424B4 Prospectus Jun 29, 2018 —
S-1MEF Filing Jun 27, 2018 —
S-1/A Amended registration statement Jun 26, 2018 —
S-1/A Amended registration statement Jun 15, 2018 —
S-1 Registration statement May 31, 2018 —

Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
STIM (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Malvern, PA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1227636
Former names
Neuronetics, Inc. (until Nov 4, 2026); NEURONETICS INC (until Aug 16, 2006)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.